Gifford Fong Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-16,100
Closed -$9.38M 132
2023
Q4
$9.38M Hold
16,100
2% 9
2023
Q3
$8.65M Hold
16,100
2.07% 8
2023
Q2
$7.55M Hold
16,100
1.77% 10
2023
Q1
$5.53M Hold
16,100
1.46% 15
2022
Q4
$5.89M Hold
16,100
1.35% 21
2022
Q3
$5.21M Hold
16,100
1.29% 20
2022
Q2
$5.22M Hold
16,100
1.22% 21
2022
Q1
$4.61M Hold
16,100
0.84% 30
2021
Q4
$4.45M Hold
16,100
0.78% 29
2021
Q3
$3.72M Hold
16,100
0.72% 40
2021
Q2
$3.69M Hold
16,100
0.72% 40
2021
Q1
$3.01M Hold
16,100
0.65% 45
2020
Q4
$2.72M Hold
16,100
0.63% 41
2020
Q3
$2.38M Hold
16,100
0.64% 37
2020
Q2
$2.64M Hold
16,100
0.8% 33
2020
Q1
$2.23M Hold
16,100
0.82% 35
2019
Q4
$2.12M Hold
16,100
0.62% 41
2019
Q3
$1.8M Hold
16,100
0.59% 47
2019
Q2
$1.78M Hold
16,100
0.6% 44
2019
Q1
$2.09M Hold
16,100
0.69% 42
2018
Q4
$1.86M Hold
16,100
0.7% 41
2018
Q3
$1.73M Hold
16,100
0.55% 50
2018
Q2
$1.37M Hold
16,100
0.47% 54
2018
Q1
$1.25M Buy
+16,100
New +$1.3M 0.51% 54

Other funds holding LLY

Gifford Fong Associates's LLY Position: Q1 2024 in Review

Gifford Fong Associates sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 16,100 shares — an estimated $9.38M sold.

Gifford Fong Associates first reported a position in LLY in Q1 2018 and held it in 24 quarters. The position peaked at $9.38M in Q4 2023. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Gifford Fong Associates reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • Gifford Fong Associates sold 16,100 Eli Lilly shares in Q1 2024, an estimated $9.38M.
  • Gifford Fong Associates first reported a position in Eli Lilly in Q1 2018 and held it in 24 quarters.
  • Gifford Fong Associates's Eli Lilly position peaked at $9.38M in Q4 2023.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Gifford Fong Associates's 13F filing for Q1 2024, filed 10 May 2024.